Aukaio Jumia

When Humira comes off of patent in 2023 it will send the manufacturing of it to the generic drug companies and drop the price to market value which may mean everyone on Medicaid and Medicare might have a chance to be treated with it. All biological drug manufacturers will be forced to drop their prices also to a reasonable level because ALL doctors will direct their patents to Humira leaving other drug companies with a product that cannot be sold because of price. In "India" a generic form of "Humira" is being manufactured and the monthly cost is only $400 which is only down a few hundred from the discounted prices in the U.S.. After "Humira" goes off patent in the U.S. even the generic "India" brand will fall in price even further. I read it may cost a drug company over a billion dollars to develop a drug but this is "Bull Hicky". For one think a drug company isn't a drug company without a team of researchers. In fact a dru